A DAD has become the first person to get a personalised NHS cancer jab in a major new programme.
Thousands more patients are now set to receive the cutting-edge experimental vaccine to stop tumours growing back.
University lecturer Elliot Pfebve, 55, was given the first of the new vaccinations — which do not prevent or cure tumours but mop up remaining cancer cells after surgery or chemotherapy.
The dad of four, from Walsall, West Mids, had chemo after bowel cancer was spotted in a routine NHS check in May 2023.
He said after his jab: “It felt wonderful to be able to take part in something which could lead to a new way of treating cancer.”
From tongue scraping to saying no, here are 12 health trends to try in 2023
The NHS will match patients to clinical trials for their specific tumours through its new Cancer Vaccine Launch Pad.
Infusions are tailored to match the DNA of unique tumours.
The vaccine — made by Covid jab maker BioNTech using similar mRNA technology — trains immune systems to fight cancer cells.
Each patient has a DNA sample taken during treatment and a vaccine is then tailored to match proteins found on their exact tumour.
Patients receive regular infusions for 12 months, starting with weekly treatment during a loading period before doses are tapered to fortnightly then every six weeks.
Professor Peter Johnson, at NHS England, said: “This is cutting-edge technology . . . a very important development in cancer treatment.
“Bringing analysis of cancer cell genetics to match somebody’s tissue is really very new. We need more treatments to prevent recurrence.”
The vaccines are free on the NHS while they are in clinical trials.
BioNTech declined to comment on the market cost.
The German firm has signed a deal to enrol 10,000 UK patients on to cancer vaccine trials by 2030.
How to de-clutter if you have a beauty stash to last you a lifetime
NHS England chief exec Amanda Pritchard said: “These vaccine trials could one day offer us a way to save more lives.”
